|
Tue, 03/18/2025 - 12:52 |
Abnormal menstrual bleeding, a likely culprit in menopausal fatigue, rarely discussed as cause |
University of M... |
|
Tue, 12/20/2022 - 13:57 |
Medical Defence Union supports national campaign to raise awareness of fatigue amongst healthcare staff |
MDU |
|
Mon, 04/12/2021 - 13:26 |
UCLA Fielding School of Public Health Scholars Work on Fatigue and Health Published Today |
UCLA School of ... |
|
Sun, 04/04/2021 - 23:23 |
Together We Can Do This Utah Artist Joins Frontline Caregivers to Unveil Artwork Honoring Healthcare Workers for Heroic Live-Saving Pandemic Efforts |
Intermountain H... |
|
Mon, 03/15/2021 - 15:34 |
Moving Research Forward to Reduce Symptoms Experienced by People with Progressive MS |
National MS Society |
|
Wed, 03/25/2020 - 07:55 |
ENHERTU Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic Breast Cancer |
Daiichi Sankyo |
|
Wed, 02/19/2020 - 05:06 |
Teva Announces Registration Trials of Deutetrabenazine in Pediatric Patients with Tourette Syndrome Did Not Meet the Primary Endpoint |
Teva Pharmaceutical |
|
Wed, 01/08/2020 - 21:11 |
Blueprint Medicines Announces FDA Approval of AYVAKIT (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor |
Blueprint Medicines |
|
Mon, 08/26/2019 - 11:42 |
An innovative diagnostic for Lyme disease |
Biodesign Institute |
|
Fri, 08/16/2019 - 10:58 |
U.S. FDA Approves INREBIC (Fedratinib) as First New Treatment in Nearly a Decade for Patients With Myelofibrosis |
BMS |
|
Thu, 08/08/2019 - 19:35 |
How to Avoid Common Pitfalls When Embracing New Telehealth Technology |
Teladoc Health |
|
Tue, 07/16/2019 - 15:13 |
APhA Launches New Well-Being Tool to Evaluate Pharmacists Stress, Burnout Levels |
American Pharma... |
|
Thu, 06/27/2019 - 13:18 |
Combination regimen reduced the risk of disease progression or death by 44 percent in newly diagnosed patients who are transplant ineligible |
Johnson and Johnson |
|
Thu, 05/30/2019 - 14:35 |
U.S. FDA Approves Supplemental New Drug Application Adding Overall Survival Data for XOSPATA (gilteritinib) |
Astellas |
|
Thu, 02/07/2019 - 23:17 |
College supports national campaign to raise awareness of fatigue amongst healthcare staff |
RCPE |
|
Fri, 01/04/2019 - 04:24 |
DPH Announces First Flu Deaths of the 2018-2019 Season; Officials Remind Delawareans to Get Vaccinated |
Delaware State ... |
|
Fri, 12/21/2018 - 18:00 |
FDA approves first treatment for rare blood disease |
FDA |
|
Thu, 12/20/2018 - 14:24 |
Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer |
Pfizer |
|
Thu, 12/20/2018 - 03:42 |
LYNPARZA (olaparib) Meets Primary Endpoint in Phase 3 SOLO-3 Trial for the Treatment of Relapsed BRCA-Mutated Advanced Ovarian Cancer |
Cubist Pharmace... |
|
Wed, 12/19/2018 - 04:35 |
LYNPARZA (olaparib) Approved by FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer |
Cubist Pharmace... |
|
Mon, 12/17/2018 - 12:29 |
Are Fitbits the answer to nurse fatigue? |
University of W... |
|
Mon, 12/17/2018 - 07:57 |
Clues to chronic fatigue syndrome in overactive immune response |
KingsCollege |
|
Sun, 12/16/2018 - 22:36 |
Adams Bros. Farming recalls lettuce and cauliflower over E. coli concerns |
Defence Commiss... |
|
Thu, 12/13/2018 - 10:44 |
Health Canada Grants Market Authorization for ORKAMBI (lumacaftor/ivacaftor) for Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease |
Vertex |
|
Wed, 12/12/2018 - 10:47 |
Havana Embassy Phenomenon: Researchers Report Acute Findings |
UniversityofPit... |
